New Life Sciences Labs OK’d in Downtown Boston

Posted by ISPE Boston
On December 1, 2022

At its November meeting, the Boston Planning & Development Agency (BPDA) approved three new life sciences lab development projects for downtown Boston: At 125 Lincoln Street,on the border between the Leather District and Chinatown, Oxford Properties plans to convert a dilapidated building housing parking, retail, and office space, into a new, 11-story research and development building […]

Biogen/Eisai Alzheimer’s Drug Shows Positive Trial Results

Posted by ISPE Boston
On December 1, 2022

Results from Eisai’s large global Phase 3 confirmatory clinical study of lecanemab have been presented at the 2022 Clinical Trials on Alzheimer’s Disease (CTAD) conference in San Francisco, California. Lecanemab is an investigational anti-amyloid beta (Aβ) protofibril antibody for the treatment of mild cognitive impairment (MCI) due to Alzheimer’s disease (AD) with confirmed presence of […]

BPDA Releases “Life Sciences Action Agenda” for Boston

Posted by ISPE Boston
On December 1, 2022

The Boston Planning & Development Agency (BPDA) has released its Life Sciences Action Agenda in response to ongoing life sciences development throughout the City of Boston. In an effort to support the industry’s built environment needs, while addressing concerns from the public in relation to the location and design of these developments, the Life Sciences Action Agenda […]

Chapter Member Anniversaries: December 2022

Posted by ISPE Boston
On December 1, 2022

Please congratulate the following members celebrating milestone anniversaries in December 2022. Their dedication to ISPE, the Boston Area Chapter and the industry is applauded! Over Twenty Years Marc Abromovitz, Novartis Pharmaceuticals Judith Bodette, Thermo Fisher VVS Jack Campion, The Hart Companies Thomas Choyce, Biogen George Dainis, Industrial Facilities Design, Inc. Amy Foley, The Richmond Group […]

Welcome New Members November 2022!

Posted by ISPE Boston
On December 1, 2022

We would like to introduce the Members who joined ISPE in November 2022, welcome them to the Chapter and encourage them (and all our members) to take advantage of the many professional development, networking and information resources available through ISPE. Fellow ISPE members are a terrific resource for help with everyday professional challenges. And the […]

Jnana Therapeutics Raises Funding, Closes Deal with Roche

Posted by ISPE Boston
On November 17, 2022

Boston biotech Jnana Therapeutics has raised $107 million in a Series C financing led by Bain Capital Life Sciences. The proceeds from the funding will be used to progress the company’s lead program in phenylketonuria (PKU), a rare genetic metabolic disease, through a clinical proof-of-concept (POC) study, and to advance additional wholly owned, potential first-in-class […]

Biogen Picks Ex-Sanofi Exec as Leader

Posted by ISPE Boston
On November 17, 2022

Biogen has appointed Christopher Viehbacher as President and Chief Executive Officer and a member of the Board of Directors, effective November 14. Viehbacher succeeds Michel Vounatsos, who has led the company since 2017. Viehbacher has extensive international experience in both large pharmaceutical companies and entrepreneurial biotech companies. After 20 years with GlaxoSmithKline, he served as […]

Merck and Moderna Pursue Cancer Vaccine

Posted by ISPE Boston
On November 10, 2022

Moderna and Merck have announced plans to jointly develop and commercialize a personalized cancer vaccine pursuant to the terms of its existing Collaboration and License Agreement. The vaccine, based on mRNA technology, is currently being evaluated for patients with high-risk melanoma in a Phase 2 clinical trial being conducted by Moderna. “We have been collaborating […]

Thermo Fisher to Acquire The Binding Site Group

Posted by ISPE Boston
On November 10, 2022

Waltham-based giant Thermo Fisher Scientific is poised to acquire UK-based specialty diagnostics company The Binding Site Group for $2.6 billion, continuing a string of acquisitions spanning several years. Upon completion of the transaction, expected in the first half of 2023, The Binding Site will become part of Thermo Fisher’s Specialty Diagnostics segment. The Binding Site […]

Chapter Member Anniversaries: November 2022

Posted by ISPE Boston
On November 8, 2022

Please congratulate the following members celebrating milestone anniversaries in November 2022. Their dedication to ISPE, the Boston Area Chapter and the industry is applauded! Over Twenty Years Charles Brown, Retired Robert Stern, Sanofi Donald Ross, A/Z Corp Peter Sampson, Pure Process Technology Timothy Curran, NV5 Edward Orourke, Azzur Group Leighton Terwilliger, Casella Process Solutions Peter […]

Page 28 of 118«‹26 272829 30 ›»